Pure Global

BERIGHT™ COVID-19 Antigen Rapid Test (Nasopharyngeal Swab) - Indonesia BPOM Medical Device Registration

BERIGHT™ COVID-19 Antigen Rapid Test (Nasopharyngeal Swab) is a medical device registered with Indonesia's BPOM (Badan Pengawas Obat dan Makanan) under Analysis ID AKL 20303120944. The device is manufactured by HANGZHOU ALLTEST BIOTECH CO., LTD from China, and is classified as Risk Class Kelas Resiko : B. The authorized representative in Indonesia is MAIN ONCOPROBE.

This page provides comprehensive regulatory information including complete registration details, manufacturer information, authorized representative details, product classification, and related products. Pure Global AI offers free access to 67,600+ Indonesia medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
BPOM Registered
Risk Class Kelas Resiko : B
BERIGHT™ COVID-19 Antigen Rapid Test (Nasopharyngeal Swab)
Analysis ID: AKL 20303120944

Risk Classification

Kelas Resiko : B

Product Class

Kelas : 2

Country of Origin

China

Authorized Representative

MAIN ONCOPROBE

AR Address

APRT.ISTANA HARMONI LT.DASAR UNIT 1M, KOMP.HARMONI PLAZA JL.SURYOPRANOTO NO.2, PETOJO UTARA

Registration Date

Feb 28, 2022

Expiry Date

Nov 05, 2025

Product Type

Serological Reagents

Respiratory viral panel multiplex nucleic acid assay

Invitro Diagnostics

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing